What is Dasatinib?

Category: Prescription Drugs

Most popular types: Sprycel

false

Dasatinib, brand name Sprycel®, is a tyrosine kinase inhibitor used to treat Ph+CML and Ph+ALL when resistance or intolerance develops to prior therapy. It targets most imatinib-resistant BCR-ABL mutation by distinctly binding to ABL-kinase to halt the proliferation of leukemia cells.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
0
Moderate
4
Mild
5
None
1

Commonly reported side effects and conditions associated with Dasatinib

Side effect Patients
Pleural effusion 2
Anxious mood 1
Black stools 1
Nausea 1
Neck movement dizziness (cervicogenic dizziness) 1
Persistent cough 1

Show all 11 reported side effects

Dosages

Based on patients currently taking Dasatinib

Dosage Patients
100 mg daily 2
70 mg daily 1
140 mg daily 1
140mg as needed 1

Why patients stopped taking Dasatinib

Multiple reasons could be selected

Reason Patients
Did not seem to work 2
Doctor's advice 1
See all 2 patients who've stopped taking Dasatinib

Duration

Currently taking Dasatinib

Duration Patients
6 months - 1 year 1
1 - 2 years 1
2 - 5 years 1
5 - 10 years 2

Stopped taking Dasatinib

Duration Patients
1 - 2 years 1
2 - 5 years 1
Adherence
Adherence Evaluations
Always 10
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 2
Not at all hard to take 8
Cost per month
Cost per month Evaluations
$200+ 1
$100-199 0
$50-99 0
$25-49 0
< $25 3
Not specified 6

What people switch to and from

Patients started taking Dasatinib after stopping:

Treatment Patients
Imatinib (Gleevec) 3
Last updated:
There are no evaluations for Dasatinib.